Maintaining and reprogramming genomic androgen receptor activity in prostate cancer (Q38190362)

30 August 2017

1 reference

title

Maintaining and reprogramming genomic androgen receptor activity in prostate cancer (English)

1 reference

30 August 2017

1 reference

Ian G Mills

1

1 reference

PubMed ID

24561445

30 August 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

30 August 2017

Nature Reviews Cancer

1 reference

30 August 2017

14

1 reference

30 August 2017

3

1 reference

30 August 2017

187-198

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3678

30 August 2017

0 references

cites work

DNA and ribonucleotide binding characteristics of two forms of the androgen receptor from rat prostates

1 reference

Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain

21 January 2018

1 reference

Structural basis for the nuclear import of the human androgen receptor

21 January 2018

1 reference

Abiraterone in metastatic prostate cancer without previous chemotherapy

21 January 2018

1 reference

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines

21 January 2018

1 reference

Overcoming mutation-based resistance to antiandrogens with rational drug design

21 January 2018

1 reference

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

21 January 2018

1 reference

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

21 January 2018

1 reference

Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients

21 January 2018

1 reference

Mapping protein-DNA interactions using ChIP-sequencing.

21 January 2018

1 reference

Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor

21 January 2018

1 reference

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

21 January 2018

1 reference

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.

21 January 2018

1 reference

The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

21 January 2018

1 reference

Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells

21 January 2018

1 reference

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

21 January 2018

1 reference

A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.

21 January 2018

1 reference

Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?

21 January 2018

1 reference

PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis

21 January 2018

1 reference

Dual roles of PARP-1 promote cancer growth and progression

21 January 2018

1 reference

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer

21 January 2018

1 reference

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

Induced chromosomal proximity and gene fusions in prostate cancer

21 January 2018

1 reference

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

21 January 2018

1 reference

The genomic landscape of prostate cancer

21 January 2018

1 reference

ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients

21 January 2018

1 reference

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

21 January 2018

1 reference

New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

21 January 2018

1 reference

Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation

21 January 2018

1 reference

Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements

21 January 2018

1 reference

H3K36 methylation antagonizes PRC2-mediated H3K27 methylation

21 January 2018

1 reference

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3

21 January 2018

1 reference

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

Putting the brakes on continued androgen receptor signaling in castration-resistant prostate cancer

21 January 2018

1 reference

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

21 January 2018

1 reference

Lupus resistance is associated with marginal zone abnormalities in an NZM murine model.

21 January 2018

1 reference

Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression

21 January 2018

1 reference

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

21 January 2018

1 reference

FOXA1 is a key determinant of estrogen receptor function and endocrine response

21 January 2018

1 reference

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

21 January 2018

1 reference

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

21 January 2018

1 reference

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth

21 January 2018

1 reference

A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes.

21 January 2018

1 reference

Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells

21 January 2018

1 reference

Prostate cancer: germline prediction for a commonly variable malignancy.

21 January 2018

1 reference

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk

21 January 2018

1 reference

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

21 January 2018

1 reference

The homeodomain protein HOXB13 regulates the cellular response to androgens

21 January 2018

1 reference

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator

21 January 2018

1 reference

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer

21 January 2018

1 reference

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

21 January 2018

1 reference

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells

21 January 2018

1 reference

NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression

21 January 2018

1 reference

Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells

21 January 2018

1 reference

Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.

21 January 2018

1 reference

Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

21 January 2018

1 reference

Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo

21 January 2018

1 reference

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

21 January 2018

1 reference

Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients

21 January 2018

1 reference

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy

21 January 2018

1 reference

Transcriptional amplification in tumor cells with elevated c-Myc.

21 January 2018

1 reference

Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer

21 January 2018

1 reference

ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.

21 January 2018

1 reference

The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription

21 January 2018

1 reference

Aberrations of EZH2 in cancer

21 January 2018

1 reference

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent

21 January 2018

1 reference

EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

21 January 2018

1 reference

NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming

21 January 2018

1 reference

Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer

21 January 2018

1 reference

The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity

21 January 2018

1 reference

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors

21 January 2018

1 reference

The role of murine models of prostate cancer in drug target discovery and validation

21 January 2018

1 reference

The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities

21 January 2018

1 reference

The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression

21 January 2018

1 reference

Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells.

21 January 2018

1 reference

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses

21 January 2018

1 reference

Titanium particles induce the immediate early stress responsive chemokines IL-8 and MCP-1 in osteoblasts

21 January 2018

1 reference

Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer

21 January 2018

1 reference

Separating the drivers from the driven: Integrative network and pathway approaches aid identification of disease biomarkers from high-throughput data

21 January 2018

1 reference

Integrating molecular and network biology to decode endocytosis

21 January 2018

1 reference

Single-tube linear DNA amplification (LinDA) for robust ChIP-seq.

21 January 2018

1 reference

A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples.

21 January 2018

1 reference

Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor

21 January 2018

1 reference

Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors

21 January 2018

1 reference

Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.

21 January 2018

1 reference

Potential pitfalls in microRNA profiling

21 January 2018

1 reference

Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays

21 January 2018

1 reference

Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies

21 January 2018

1 reference

Amplitude modulation of androgen signaling by c-MYC.

21 January 2018

1 reference

Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation

21 January 2018

1 reference

Coordinated regulation of polycomb group complexes through microRNAs in cancer.

21 January 2018

1 reference

The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer

21 January 2018

1 reference

Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop

21 January 2018

1 reference

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis

21 January 2018

1 reference

Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer

21 January 2018

1 reference

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

21 January 2018

1 reference

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

21 January 2018

1 reference

HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling

21 January 2018

1 reference

NF-kappaB regulates androgen receptor expression and prostate cancer growth

21 January 2018

1 reference

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

21 January 2018

1 reference

EFFECT OF ORCHIECTOMY AND IRRADIATION ON CANCER OF THE PROSTATE

21 January 2018

1 reference

Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis

31 March 2020

1 reference

Recurrent gene fusions in prostate cancer: their clinical implications and uses

31 March 2020

1 reference

Role of the TMPRSS2-ERG gene fusion in prostate cancer

31 March 2020

1 reference

The FoxA factors in organogenesis and differentiation

31 March 2020

1 reference

Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element

31 March 2020

1 reference

Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage

31 March 2020

1 reference

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells

31 March 2020

1 reference

Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer

31 March 2020

1 reference

Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1

31 March 2020

1 reference

SRC-3 is required for prostate cancer cell proliferation and survival

31 March 2020

1 reference

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

31 March 2020

1 reference

Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer

31 March 2020

1 reference

Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24561445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interrogating genomic and epigenomic data to understand prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24561445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24561445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRC3678

1 reference

PubMed ID

24561445

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24561445